Title: Christopher Dixon Creech: Innovator in Cyclic Nucleotide-Gated Ion Channels
Introduction
Christopher Dixon Creech is a notable inventor based in the United States. He has made significant contributions to the field of biotechnology, particularly in the study of cyclic nucleotide-gated ion channels. His work focuses on the molecular mechanisms that govern these channels, which play a crucial role in various physiological processes.
Latest Patents
Christopher Dixon Creech holds a patent for "CNG3B: A Novel Cyclic Nucleotide-Gated Cation Channel." This invention provides isolated nucleic acid and amino acid sequences of CNG3B, along with antibodies to CNG3B. It also includes methods for detecting CNG3B and screening for modulators of cyclic nucleotide-gated ion channels using biologically active CNG3B. Furthermore, the invention outlines a method for screening mutations of human CNG3B genes and identifying the three-dimensional structure of human CNG3B polypeptides.
Career Highlights
Christopher Dixon Creech is associated with Applied Genetic Technologies Corporation, where he applies his expertise in genetic technologies. His work at the company emphasizes the importance of understanding ion channels in the context of genetic research and therapeutic development.
Collaborations
[This section has been skipped due to space constraints.]
Conclusion
Christopher Dixon Creech is a dedicated inventor whose work on cyclic nucleotide-gated ion channels has the potential to advance our understanding of genetic mechanisms and therapeutic applications. His contributions to biotechnology are noteworthy and reflect his commitment to innovation in the field.